NIAID PROGRAM ANNOUNCEMENTS: UPDATE NIH GUIDE, Volume 25, Number 37, November 1, 1996 P.T. 34 Keywords: Grants Administration/Policy+ National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID) published the notice, Continuation and Inactivation of NIAID Program Announcements, in the NIH GUIDE, Vol. 25, No. 18, June 7, 1996. This notice addresses three topics: (1) it defines the effect of continuation and inactivation of program announcements on the potential for funding of grant applications; (2) it announces a new NIAID policy - that most future NIAID Program Announcements (PAs) will remain active for three years; and (3) it updates the listing of NIAID Program Announcements (PAs) being continued and being inactivated. 1. PA CONTINUATION AND INACTIVATION NIAID gives special consideration for funding, including award of grants beyond the NIAID percentile and priority score paylines, to applications submitted in response to active (new and continuing) PAs. NIAID supports highly scientifically meritorious applications in all areas of research within its mission. PA inactivation simply means that special consideration for funding beyond normal paylines will NO LONGER be given to applications on the research topics identified in the inactivated PAs. However, such applications will be accepted, reviewed, and considered for funding according the usual procedures. 2. NIAID THREE YEAR PROGRAM ANNOUNCEMENTS Historically, NIAID PAs have been issued for different durations. Some were issued as open-ended PAs; that is, investigators could continue to submit applications in response to a PA until NIAID announced its termination in the NIH Guide. Others were issued for one or two or three years of receipt dates following publication. Henceforward, virtually all new NIAID PAs will be issued for three years of standard receipt dates following their publication in the NIH Guide for Grants and Contracts. Each PA will identify the receipt dates for applications. This will ensure that there is adequate time for investigators to develop and propose their research plans at the same time as ensuring that PAs are not kept active beyond their useful life. 3. NIAID PA CONTINUATIONS AND INACTIVATIONS. NIAID will continue to support selected previously published PAs and is inactivating other older PAs. Further, additional PAs will be inactivated and new ones published in the future as NIAID continues to adjust and expand the use of PAs to inform the scientific community of its areas of current research emphasis (See NIH Guide, Volume 25, April 19, 1996 for NIAID Notice on Program Announcements and Research Emphasis Areas). A listing of all active NIAID PAs plus a listing of future PAs given concept approval by the National Advisory Allergy and Infectious Diseases Council is kept current and can be found on the NIAID WWW site at: http://www.niaid.nih.gov/newsletter/maya/pa-table.htm Clicking on the title of any active PA will link the user to the full text of the PA. CONTINUATIONS. NIAID will continue to give special consideration for funding to applications in response to the following PAs. For each PA, the number, title, and date of publication in the NIH Guide for Grants and Contracts is cited below. In addition to finding a PA via the NIAID WWW site (see above), PAs can be obtained from the NIH Grants and Contracts Home Page (http://www.nih.gov:80/grants). On this home page, for PAs published in 1994 or earlier, select "NIH GUIDE FOR GRANTS AND CONTRACTS"; then select "NIH Guide-Flat Text Files Printed Edition"; then select the publication date(s) for the PA(s) in which you are interested. For PAs published in 1995 and 1996, select "Program Announcements-Full Text." AND ALL NIAID PROGRAM ANNOUNCEMENTS PUBLISHED IN THE NIH GUIDE AFTER SEPTEMBER 6, 1996. PA-93-041 Minority Investigators in Asthma and Allergy, January 22, 1993 PA-93-108 Behavioral Research in Sexually Transmitted Diseases, September 3, 1993 PA-94-019 Infectious Causes of Diarrhea/Wasting Syndrome in People with AIDS, December 17, 1993 PA-94-062 Environmental Agents and Asthma, April 29, 1994 PA-94-092 New Insights into Chronic Fatigue Syndrome, August 4, 1994 PA-94-095 Drug Discovery for Opportunistic Infections Associated with AIDS, September 16, 1994 PAR-95-047 National Cooperative Drug Discovery Groups, HIV Treatment, April 14, 1995 PA-95-062 Fellowships and Career Development in Inflammatory Bowel Disease, May 19, 1995 PA-96-014 Models for HIV Disease and AIDS-related Malignancies, January 26, 1996 PAR-96-031 NIDDK-NIAID International Collaboration: Small Grant Awards, March 8, 1996 PA-96-048 Expanded Research on Emerging Diseases, May 3, 1996 PA-96-051 Role of Microbes in Autoimmune and Immune-Mediated Diseases, May 10, 1996 PA-96-053 Gender in the Pathogenesis of Autoimmunity: Mechanisms, May 10, 1996 PAR-96-060 Acute Infection and Early Disease Research Network, June 28, 1996 PA-96-061 Modern Vaccines for Mycoses and Measles, June 21, 1996 PA-96-067 Molecular Correlates of Pathogenesis in Parasitic Diseases, July 26, 1996 PA-96-068 Innovative Drug Discovery Research in AIDS Opportunistic Infections, August 2, 1996 PA-96-069 Collaborations for Advanced Strategies in Opportunistic Infections, August 9, 1996 PA-96-070 Chronic Fatigue Syndrome Pathophysiology, August 16, 1996 PA-96-072 Mechanisms of AIDS Pathogenesis, September 6, 1996. INACTIVATIONS. The following program announcements (PAs) are being inactivated; NIAID will no longer give special consideration for funding to applications in response to these PAs. This notice is effective immediately and applies to the application receipt deadlines of February 1, 1997 and after. ALL NIAID-SPONSORED PAs PUBLISHED IN THE NIH GUIDE FOR GRANTS AND CONTRACTS PRIOR TO NOVEMBER 6, 1992. PA-93-014 The Immunology of Aging, November 6, 1992 PA-93-034 Mucosal Immunity in the Urogenital Tract, January 8, 1993 PA-93-037 Asthma as a T-Cell-Mediated Disease, January 15, 1993 PA-93-042 Cytokines and Adhesion in Allergy and Inflammation, January 22, 1993 PA-93-049 Neurological Aspects of Lyme Disease, February 6, 1993 PA-93-061 Congenital Cytomegalovirus: Study of Infection and Sequelae, March 5, 1993 PA-93-085 Biological Factors Influencing Sexual Transmission of HIV, May 21, 1993 PA-93-090 Basic Rubella Research Leading to Improved Rubella Vaccines, June 4, 1993 PA-93-096 Research on DNA Vaccines for Infectious Diseases, June 18, 1993 PA-93-105 Helicobacter Pylori Pathogenesis, August 8, 1993 PA-93-114 Autoimmune Endocrine Disease, September 24, 1993 PA-94-023 HIV-Related Therapeutics in Drug Users, January 7, 1994 PA-94-049 Studies on Environmental Toxicants and the Immune System, March 18, 1994 INQUIRIES For questions or further information, contact: Office of the Director Division of Extramural Activities National Institute of Allergy and Infectious Diseases Solar Building, Room 3C20 Bethesda, MD 20892-7610 Telephone: (301) 496-7291 FAX: (301) 402-0369 Email: ac20a@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |